Global HEOR · Market Access · Value Strategy

Illuminating value
in healthcare products.

A specialist partner in health economics, market access, and value strategy — navigating the path from evidence to reimbursement.

HTA Submissions
Global Value Dossiers
Cost-Effectiveness Modeling
Payer Evidence Strategy
Real-World Evidence
NICE · G-BA · HAS · AIFA · CMS
Budget Impact Models
Coverage, Coding & Payment
Digital Health Reimbursement
Patient-Reported Outcomes
HTA Submissions
Global Value Dossiers
Cost-Effectiveness Modeling
Payer Evidence Strategy
Real-World Evidence
NICE · G-BA · HAS · AIFA · CMS
Budget Impact Models
Coverage, Coding & Payment
Digital Health Reimbursement
Patient-Reported Outcomes

We work with the companies changing healthcare — and help them get paid for it.

Medical Devices

Coverage, codes, and payment — we get your technology through the door.

Economic evidence, coding strategy, and payer tools that turn clinical performance into reimbursed adoption.

Pharmaceutical & Biotech

From HTA submission to payer approval — we make the case your science deserves.

Value dossiers, economic models, and HTA navigation across US and international markets.

Digital Health

A reimbursement strategy as innovative as your product.

Coding routes, payer-ready evidence, and the economic argument for a category still defining itself.

The evidence, the economics, and the access strategy — at every stage.

From early evidence planning through to post-market access — the right expertise at every stage of development.

Preclinical

Design for reimbursement from day one — before costly evidence gaps are locked in.

  • •Burden-of-illness and cost-of-care analyses
  • •Early cost-effectiveness and pricing scenarios
  • •Evidence planning aligned to future payer needs
  • •Payer landscape and policy assessment
  • •Preliminary pricing and access feasibility
  • •Stakeholder and market segmentation

Clinical

Generate the payer-facing evidence and pricing strategy you'll need at submission — while you still can.

  • •Payer-relevant trial design and endpoint selection
  • •Interim cost-effectiveness modeling and value forecasts
  • •Comparator and standard-of-care analyses
  • •RWE planning for post-launch validation
  • •Code applications (CPT, NTAP, TPT)
  • •Early pricing and launch sequencing strategy
  • •Engagement with payers and HTA advisors

Pre-Launch & Commercial

Secure reimbursement, drive adoption, and protect access long after launch.

  • •Full economic and budget impact modeling
  • •HTA submissions and value dossiers
  • •Real-world evidence generation and value publications
  • •Value-based contracts and outcomes tracking
  • •Payer negotiation and value communication tools
  • •Field and provider education
  • •Access maintenance through post-market data

Our results.

65+HTA Submissions
90%Client Return Rate
100+Diagnostic and Therapeutic Areas

Precisely what we do.

Market Intelligence

Strategic market intelligence delivered early, informing product planning, de-risking commercialization, and aligning innovation with payer, provider, and patient needs.

  • •Market assessments and payer landscape analysis
  • •Strategic product planning
  • •Competitive landscape analysis
  • •Pricing strategy
Coding Strategy & Development

We help you navigate the evolving coding landscape and ensure your innovation is accurately and optimally represented within reimbursement systems.

  • •New code applications (CPT, ICD-10-PCS, HCPCS), including society support and CPT pull-through
  • •Coding gap analyses
  • •Procedure-to-technology mapping
  • •Provider and internal team education
Payer Coverage Strategy & Evidence Development

Coverage is earned through clarity, credibility, and trusted advisory relationships. We build strategies that align your clinical evidence with payer expectations.

  • •Payer coverage landscape assessments and proactive coverage surveillance
  • •Clinical evidence mapping and health economic support
  • •Payer value dossiers and clinical compendium development
  • •Real-world evidence generation, study protocol development, and HEOR
Payment Strategy & Modeling

We model financial impact and optimize payment pathways to support sustainable access and provider adoption across government and commercial payers.

  • •Payment benchmarking across government and commercial payers
  • •NTAP and TPT support for new technology payments
  • •Inpatient and outpatient reimbursement strategy
  • •Retrospective claims analytics to support payment strategy
Commercial Readiness

We equip your commercial and clinical teams with the practical resources that bridge the gap between strategy and execution — ensuring field teams can have credible, evidence-based conversations with providers and payers from day one.

  • •DRG/APC impact analyses
  • •NTAP and TPT education and facility pull-through
  • •Facility proformas and budget impact models
  • •Field team reimbursement education and billing tools

Let's get your product reimbursed.

Tell us about your asset and where you are in the access journey — we'll take it from there.